Approval · Notice of Compliance 3541 · 2003
EFFEXOR: Notice of Compliance 3541
Issued March 14, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3541
- Date
- March 14, 2003
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antidepressant, anxiolytic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EFFEXOR | 02103664 | — |
| EFFEXOR | 02103672 | — |
| EFFEXOR | 02103680 | Cancelled Post Market |
| EFFEXOR | 02103699 | Cancelled Post Market |
| EFFEXOR | 02103702 | Cancelled Post Market |
| EFFEXOR | 02103710 | — |
| EFFEXOR XR | 02237279 | Marketed |
| EFFEXOR XR | 02237280 | Marketed |
| EFFEXOR XR | 02237281 | — |
| EFFEXOR XR | 02237282 | Marketed |
Medicinal ingredients
- VENLAFAXINE HYDROCHLORIDE 12.5 MG per TAB
- VENLAFAXINE HYDROCHLORIDE 25 MG per TAB
- VENLAFAXINE HYDROCHLORIDE 37.5 MG per TAB
- VENLAFAXINE HYDROCHLORIDE 50 MG per TAB
- VENLAFAXINE HYDROCHLORIDE 75 MG per TAB
- VENLAFAXINE HYDROCHLORIDE 100 MG per TAB
- VENLAFAXINE HYDROCHLORIDE 37.5 MG per CAP
- VENLAFAXINE HYDROCHLORIDE 75 MG per CAP
- VENLAFAXINE HYDROCHLORIDE 100 MG per CAP
- VENLAFAXINE HYDROCHLORIDE 150 MG per CAP